| Elective cancer surgery in COVID-19–free surgical pathways during the SARS-CoV-2 pandemic: an international, multicenter, comparative cohort study JC Glasbey, D Nepogodiev, JFF Simoes, O Omar, E Li, ML Venn, PGDME, ... Journal of Clinical Oncology 39 (1), 66-78, 2021 | 263 | 2021 |
| Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study J Glasbey, A Ademuyiwa, A Adisa, E AlAmeer, AP Arnaud, F Ayasra, ... The Lancet Oncology 22 (11), 1507-1517, 2021 | 236 | 2021 |
| SUCCOR study: an international European cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 … L Chiva, V Zanagnolo, D Querleu, N Martin-Calvo, J Arévalo-Serrano, ... International Journal of Gynecologic Cancer 30 (9), 2020 | 209 | 2020 |
| COVID-19 global pandemic: options for management of gynecologic cancers PT Ramirez, L Chiva, AGZ Eriksson, M Frumovitz, A Fagotti, AG Martin, ... Obstetrical & Gynecological Survey 75 (7), 410-411, 2020 | 206 | 2020 |
| Sparing fertility in young patients with endometrial cancer L Chiva, F Lapuente, L González-Cortijo, N Carballo, JF García, A Rojo, ... Gynecologic oncology 111 (2), S101-S104, 2008 | 183 | 2008 |
| European Society of Gynaecological Oncology (ESGO) guidelines for ovarian cancer surgery D Querleu, F Planchamp, L Chiva, C Fotopoulou, D Barton, D Cibula, ... International Journal of Gynecologic Cancer 27 (7), 2017 | 167 | 2017 |
| ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors D Timmerman, F Planchamp, T Bourne, C Landolfo, A du Bois, L Chiva, ... International Journal of Gynecologic Cancer 31 (7), 2021 | 154 | 2021 |
| European Society of Gynaecologic Oncology quality indicators for advanced ovarian cancer surgery D Querleu, F Planchamp, L Chiva, C Fotopoulou, D Barton, D Cibula, ... International Journal of Gynecologic Cancer 26 (7), 2016 | 141 | 2016 |
| Ovarian low-grade serous carcinoma: a comprehensive update I Diaz-Padilla, AL Malpica, L Minig, LM Chiva, DM Gershenson, ... Gynecologic oncology 126 (2), 279-285, 2012 | 126 | 2012 |
| Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer L Alonso-Alconada, L Muinelo-Romay, K Madissoo, A Diaz-Lopez, ... Molecular cancer 13, 1-10, 2014 | 114 | 2014 |
| The current role of neoadjuvant chemotherapy in the management of cervical carcinoma A González-Martín, L González-Cortijo, N Carballo, JF Garcia, F Lapuente, ... Gynecologic oncology 110 (3), S36-S40, 2008 | 109 | 2008 |
| A critical appraisal of hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of advanced and recurrent ovarian cancer LM Chiva, A Gonzalez-Martin Gynecologic Oncology 136 (1), 130-135, 2015 | 102 | 2015 |
| Perspectives, fears and expectations of patients with gynaecological cancers during the COVID‐19 pandemic: A Pan‐European study of the European Network of Gynaecological Cancer … M Gultekin, S Ak, A Ayhan, A Strojna, A Pletnev, A Fagotti, AM Perrone, ... Cancer Medicine 10 (1), 208-219, 2021 | 93 | 2021 |
| FIGO stage IV epithelial ovarian, fallopian tube and peritoneal cancer revisited B Ataseven, LM Chiva, P Harter, A Gonzalez-Martin, A du Bois Gynecologic oncology 142 (3), 597-607, 2016 | 87 | 2016 |
| Surgical treatment of recurrent cervical cancer: state of the art and new achievements LM Chiva, F Lapuente, L González-Cortijo, A González-Martín, A Rojo, ... Gynecologic oncology 110 (3), S60-S66, 2008 | 80 | 2008 |
| European Society of Gynaecological Oncology guidelines for the peri-operative management of advanced ovarian cancer patients undergoing debulking surgery C Fotopoulou, F Planchamp, T Aytulu, L Chiva, A Cina, Ö Ergönül, ... International Journal of Gynecologic Cancer 31 (9), 2021 | 65 | 2021 |
| What should we expect after a complete cytoreduction at the time of interval or primary debulking surgery in advanced ovarian cancer? L Chiva, F Lapuente, T Castellanos, S Alonso, A Gonzalez-Martin Annals of surgical oncology 23, 1666-1673, 2016 | 64 | 2016 |
| HIPEC: HOPE or HYPE in the fight against advanced ovarian cancer? C Fotopoulou, J Sehouli, S Mahner, P Harter, E Van Nieuwenhuysen, ... Annals of Oncology 29 (8), 1610-1613, 2018 | 52 | 2018 |
| Brief report about the role of hyperthermic intraperitoneal chemotherapy in a prospective randomized phase 3 study in recurrent ovarian cancer from Spiliotis et al P Harter, A Reuss, J Sehouli, L Chiva, A du Bois International Journal of Gynecologic Cancer 27 (2), 2017 | 48 | 2017 |
| Hyperthermic intraperitoneal chemotherapy does not improve survival in advanced ovarian cancer I Vergote, P Harter, L Chiva Cancer 125, 4594-4597, 2019 | 45 | 2019 |
